Trade PRQR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ProQR Therapeutics N.V. (PRQR) is trading at US$1.86, up 0.00% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$330.22M. Over the past 52 weeks, PRQR has traded between US$1.33 and US$3.10. On Syfe you can trade PRQR with $0 commission and add it to your watchlist.
| Previous close | US$1.86 |
|---|---|
| Market cap | US$330.22M |
| 52-week range | US$1.33 – US$3.10 |
| Volume | 617.31K |
| Exchange | US |
Add to Watchlist
Set Price Alert
ProQR Therapeutics N.V.
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.
Year: 2014
Proqr Therapeutics Insider Bought Shares Worth $353,960, According to a Recent SEC Filing
Aug 3, 8:27 PM · MT Newswires
Proqr Therapeutics N.v. Insider Bought Shares Worth $257,925, According to a Recent SEC Filing
Jul 21, 12:06 PM · MT Newswires
ProQR Registers Shares for Resale by Investor
Jul 6, 9:38 PM · MT Newswires
Chardan Research Adjusts ProQR Therapeutics Price Target to $3 From $4, Maintains Buy Rating
Jun 26, 12:17 PM · MT Newswires
ProQR Therapeutics N.V. (PRQR) stock is trading at US$1.86, 0.00% from the previous close of US$1.86.
The market cap for ProQR Therapeutics N.V. (PRQR) stock is approximately US$330.22M.
The 52-week high for ProQR Therapeutics N.V. (PRQR) stock is US$3.10.
The 52-week low for ProQR Therapeutics N.V. (PRQR) stock is US$1.33.
ProQR Therapeutics N.V. (PRQR) does not currently pay a dividend.
Stay on top of PRQR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
